webleads-tracker

US Sunshine Act

Sunshine Act Begins: Conflict Of Interest Includes Board Members, Extends Beyond Pharma

Pharma Compliance Info Sunshine Act Begins: Conflict Of Interest Includes Board Members, Extends Beyond Pharma US Sunshine Act

Nearly one health care company board member in every 10 also serves as a top academic from a renowned medical and research institution in the United States, a new study finds. This adds up to a total of 279 health care company board members affiliated with 85 non-profit academic institutions. While the Sunshine Act reveals the fees and gifts doctors receive from pharmaceutical companies, Obamacare’s transparency clause does not expose a professor moonlighting as a board member, say the researchers. Yet, such dual obligations pose a major conflict of interest. To read the article by Susan Scutti

Read More »

Financial Disclosures in Academic Publications and the Sunshine Act: A Concordance Study

Pharma Compliance Info Financial Disclosures in Academic Publications and the Sunshine Act: A Concordance Study US Sunshine Act

Aims: To assess the concordance between conflicts of interest reported by physicians in three major scientific journals and industry-reported payments available through the Open Payments Program (OPP) database. Study Design: Comparative cross-sectional surveys. Place and Duration of Study: United States allopathic and osteopathic physicians with publications in American Journal of Ophthalmology, JAMA Ophthalmology, and Ophthalmology accepted after January 1, 2014 and published from May 2014 through October 2014. Methodology: We compared physicians’ self-reported conflicts of interest in their academic publications to industry-reported payments in the Centers for Medicare & Medicaid Services OPP database. Authors were categorized based on concordance between …

Read More »

Sunshine Act shows vascular surgeons reap more industry payments

Pharma Compliance Info Sunshine Act shows vascular surgeons reap more industry payments US Sunshine Act

CHICAGO – Drug- and device makers paid $3.4 billion to U.S. physicians and hospitals in the last 5 months of 2013, according to first-year data from the Centers for Medicare & Medicaid Services (CMS) Open Payments program, Dr. John Blebea reported at the annual meeting of the Midwestern Vascular Surgical Society. To read the article by the ACS Surgery News

Read More »

CMS Seeks Comment On Adding Open Payments Data To “Physician Compare” Website

Pharma Compliance Info CMS Seeks Comment On Adding Open Payments Data To “Physician Compare” Website US Sunshine Act

Posted by Thomas Sullivan CMS launched the first phase of Physician Compare on December 30, 2010, and so far the website mainly contains physician identification information as well as whether they participate in various “Quality” programs, including the Physician Quality Reporting System (PQRS), Electronic Prescribing (eRX) Incentive Programs, and Electronic Health Records. (You can search your doctor by name or specialty here). In its recently released Call for Comment (see page 123), CMS proposed to add additional data to each doctor’s Physician Compare page, including Open Payments data. To read the article by Thomas Sullivan

Read More »
X